Skip to main content
. Author manuscript; available in PMC: 2012 Apr 11.
Published in final edited form as: Transplantation. 2011 Mar;91(6):652–656. doi: 10.1097/TP.0b013e31820ae4ac

Table 2.

Characteristics of the study population according to CYP3A5 genotype.

CYP3A5*1/*3 (n=7) CYP3A5*3/*3 (n=21) P values
Age of recipient (years) 53±12 51±12 0.5926
Male sex (n; %) 3 (43%) 15 (71%) 0.2075
Weight (kg) 64±11 66±19 0.5211
Years since transplantation (range) 10 (0.6–19) 7 (1.1–18) 0.7908
Mycophenolate mofetil cotreatment (n; %) 5 (71%) 18 (85%) 0.4318
Corticosteroid dose (range) 2.1 mg (0–5) 2.5 mg (0–10) 0.2057
Serum creatinine levels 130.7 μmol/l 131.2 μmol/l 0.6863